Global Omega-3 Ingredients for Pharmaceuticals Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Omega-3 Ingredients for Pharmaceuticals Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Omega 3 ingredients are naturally occurring polyunsaturated fatty acids and nutrients that are essential for optimal human health. There are three kinds of omega-3 ingredients, namely, eicosapentaenoic acid (EPA), alpha-linoleic acid (ALA), and docosahexaenoic acid (DHA). EPA and DHA are mostly extracted from fish and ALA is mainly extracted from plants sources such as seeds and nuts.
Omega-3 Ingredients for Pharmaceuticals report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Omega-3 Ingredients for Pharmaceuticals market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cardiovascular Diseases and Autoimmune Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Omega-3 Ingredients for Pharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Omega-3 Ingredients for Pharmaceuticals key manufacturers include Avestia Pharma, Novasep, AbbVie Inc, KD Pharma Group, BASF SE, Corbion, DSM, AstraZeneca and GSK plc, etc. Avestia Pharma, Novasep, AbbVie Inc are top 3 players and held % sales share in total in 2022.
Omega-3 Ingredients for Pharmaceuticals can be divided into Docosahexaenoic Acid, Eicosapentaenoic Acid and Alpha-Linolenic Acid,, etc. Docosahexaenoic Acid is the mainstream product in the market, accounting for % sales share globally in 2022.
Omega-3 Ingredients for Pharmaceuticals is widely used in various fields, such as Cardiovascular Diseases, Autoimmune Diseases, Bone & Joint Disorders and Neurological Disorders, etc. Cardiovascular Diseases provides greatest supports to the Omega-3 Ingredients for Pharmaceuticals industry development. In 2022, global % sales of Omega-3 Ingredients for Pharmaceuticals went into Cardiovascular Diseases filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Omega-3 Ingredients for Pharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Avestia Pharma
Novasep
AbbVie Inc
KD Pharma Group
BASF SE
Corbion
DSM
AstraZeneca
GSK plc
Fresenius Kabi AG
Croda International Plc
AMARIN CORPORATION
ANI Pharmaceuticals, Inc
Epax
Strides Pharma Science Limited
Pharma Marine AS
KinOmega Biopharm Inc
Camber Pharmaceuticals, Inc
Segment by Type
Docosahexaenoic Acid
Eicosapentaenoic Acid
Alpha-Linolenic Acid
Cardiovascular Diseases
Autoimmune Diseases
Bone & Joint Disorders
Neurological Disorders
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Omega-3 Ingredients for Pharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Omega-3 Ingredients for Pharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Omega-3 Ingredients for Pharmaceuticals industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Omega-3 Ingredients for Pharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Omega-3 Ingredients for Pharmaceuticals introduction, etc. Omega-3 Ingredients for Pharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Omega-3 Ingredients for Pharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Omega-3 Ingredients for Pharmaceuticals report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Omega-3 Ingredients for Pharmaceuticals market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cardiovascular Diseases and Autoimmune Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Omega-3 Ingredients for Pharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Omega-3 Ingredients for Pharmaceuticals key manufacturers include Avestia Pharma, Novasep, AbbVie Inc, KD Pharma Group, BASF SE, Corbion, DSM, AstraZeneca and GSK plc, etc. Avestia Pharma, Novasep, AbbVie Inc are top 3 players and held % sales share in total in 2022.
Omega-3 Ingredients for Pharmaceuticals can be divided into Docosahexaenoic Acid, Eicosapentaenoic Acid and Alpha-Linolenic Acid,, etc. Docosahexaenoic Acid is the mainstream product in the market, accounting for % sales share globally in 2022.
Omega-3 Ingredients for Pharmaceuticals is widely used in various fields, such as Cardiovascular Diseases, Autoimmune Diseases, Bone & Joint Disorders and Neurological Disorders, etc. Cardiovascular Diseases provides greatest supports to the Omega-3 Ingredients for Pharmaceuticals industry development. In 2022, global % sales of Omega-3 Ingredients for Pharmaceuticals went into Cardiovascular Diseases filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Omega-3 Ingredients for Pharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Avestia Pharma
Novasep
AbbVie Inc
KD Pharma Group
BASF SE
Corbion
DSM
AstraZeneca
GSK plc
Fresenius Kabi AG
Croda International Plc
AMARIN CORPORATION
ANI Pharmaceuticals, Inc
Epax
Strides Pharma Science Limited
Pharma Marine AS
KinOmega Biopharm Inc
Camber Pharmaceuticals, Inc
Segment by Type
Docosahexaenoic Acid
Eicosapentaenoic Acid
Alpha-Linolenic Acid
Segment by Application
Cardiovascular Diseases
Autoimmune Diseases
Bone & Joint Disorders
Neurological Disorders
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Omega-3 Ingredients for Pharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Omega-3 Ingredients for Pharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Omega-3 Ingredients for Pharmaceuticals industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Omega-3 Ingredients for Pharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Omega-3 Ingredients for Pharmaceuticals introduction, etc. Omega-3 Ingredients for Pharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Omega-3 Ingredients for Pharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.